top of page

Drug Shortages Australia Pro Pharmaceuticals S19A Brochure

May 27, 2023
1 min read

Updated: Aug 28

Historical supply notice: This article relates to a previous medicine shortage or regulatory approval. Availability and regulatory status may have changed. Healthcare professionals should contact Pro Pharmaceuticals Group to confirm the current supply position.

For current Australian shortage and supply information, see medicine shortages in Australia.


We have compiled a comprehensive PDF brochure that can be downloaded from our products page. This brochure contains detailed information about the multiple S19A products we supply. It is regularly updated to include the current products we have S19A approval for, their respective expiry dates, and whether they are listed on the PBS.


For our SAS (Special Access Scheme) products, they can be specifically requested by contacting us directly. Please feel free to reach out to us for further information. You can also refer to the Pro Pharm S19A List for a detailed overview of our S19A approved products.


Drug Shortages Australia


Drug Shortages Australia
Drug Shortages Australia

Recent Posts
Archive
Search By Tags
Follow Us
  • Twitter Social Icon
  • Google+ Basic Square

Legal & Trademark Notice
© 2026 Pro Pharmaceuticals Group Pty Ltd. All rights reserved.
Pro PG, CheckMed, and their respective logos are registered trademarks owned worldwide by Pro Pharmaceuticals Group Pty Ltd.
Pro Pharmaceuticals Group operates globally through associated entities, including CTS Pharmaceuticals Pty Ltd (Australia), Jemstar Sp. z o.o. (Poland), and Pro Pharmaceuticals Group NZ Ltd (New Zealand).

International Tax Registrations:
ABN 20 605 457 430 (Australia) | VAT DE401757398 (EU VAT ID) | Steuernummer 15/460/00493 (Germany) | VAT PL5263362401 (Poland) | VAT NL825524295B01 (Netherlands).

bottom of page